Portal de Periódicos da CAPES

Eplerenone, a new treatment for an old problem: Retinitis pigmentosa with recalcitrant macular edema

2017; Elsevier BV; Volume: 93; Issue: 1 Linguagem: Espanhol

10.1016/j.oftale.2017.05.012

2173-5794

R. Campos Polo, C. Rubio Sánchez, D.M. García Guisado, M. Luque,

Drug-Induced Ocular Toxicity

The case involves a 35-year-old man, with a history of retinitis pigmentosa, who presented with a bilateral cystoid macular edema associated with bilateral epiretinal membrane, which was resistant to treatment with oral acetazolamide and intravitreal bevacizumab. The treatment with oral eplerenone was able to improve the visual acuity and macular thickness of this patient. A variety of treatments have been proposed for the management of cystoid macular edema, associated with retinitis pigmentosa, with variable results. The treatment with oral eplerenone might be a good option for the control of this condition. Varón de 35 años, con antecedentes personales de retinosis pigmentaria, que presentó un edema macular quístico bilateral asociado a membrana epirretiniana bilateral resistente a tratamiento con acetazolamida oral y bevacizumab intravítreo. El tratamiento con eplerenona oral fue capaz de mejorar la agudeza visual y el grosor macular de este paciente. Se han propuesto numerosos tratamientos para el manejo del edema macular quístico asociado a retinosis pigmentaria, con resultados variables. El tratamiento con eplerenona oral podría ser una buena opción para el control de esta entidad.